Physician profile
Shaffer Mok
NPI 1275878787
$42,404.63
in general payments reported to CMS, 2019-2025
16 companies · $9,480 in 2025
The $9,480 reported for 2025 was more than what 93% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,321 · 2020: $7,831 · 2021: $9,767 · 2022: $3,226 · 2023: $1,359 · 2024: $9,421 · 2025: $9,480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $19K · Travel and Lodging: $1,385 · Food and Beverage: $320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,556.00 |
| Travel and Lodging | $1,384.54 |
| Food and Beverage | $319.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conmed Corporation | $19,213.19 | 2020-2022 | |
| US Endoscopy | $9,825.00 | 2023-2025 | |
| Amgen INC. | $6,823.50 | 2024 | Uplizna |
| Pentax of America, INC. | $1,907.50 | 2023-2024 | |
| Steris Corporation | $1,480.06 | 2025 | |
| Covidien LP | $851.17 | 2019-2020 | |
| Zyla Life Sciences, INC. | $600.00 | 2019 | |
| Mauna Kea Technologies, INC. | $482.01 | 2022 | |
| Medtronic, INC. | $328.98 | 2022-2024 | Prodigi, Nexpowder |
| Abbvie INC. | $262.61 | 2019 | |
| Axonics, INC. | $195.50 | 2022 | |
| Janssen Scientific Affairs, LLC | $125.00 | 2019 | |
| Boston Scientific Corporation | $123.42 | 2019-2020 | |
| Ethicon US, LLC | $105.23 | 2019 | |
| Cook Medical LLC | $66.22 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $15.24 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shaffer Mok listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.